1. Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
   Mariana Cooke et al, 2022, Science Signaling CrossRef
2. Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer
   Rumeysa Ozyurt et al, 2023, Molecular Cancer Therapeutics CrossRef
3. Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions
   Rishi Kant Singh et al, 2023, Life Sciences CrossRef
4. PKCα inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability
   Jiaojiao Yu et al, 2024, Acta Pharmaceutica Sinica B CrossRef
5. lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
   Jianhua Zhang et al, 2021, OncoTargets and Therapy CrossRef
6. AXL – a new player in resistance to HER2 blockade
   Anna Adam-Artigues et al, 2023, Cancer Treatment Reviews CrossRef
7. A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
   Ahmad Nasimian et al, 2023, International Journal of Molecular Sciences CrossRef
8. The PKC universe keeps expanding: From cancer initiation to metastasis
   Nilufar Rahimova et al, 2020, Advances in Biological Regulation CrossRef
9. Protein kinase C signaling “in” and “to” the nucleus: Master kinases in transcriptional regulation
   Marcelo G. Kazanietz et al, 2024, Journal of Biological Chemistry CrossRef
10. MZF-1/Elk-1 interaction domain as therapeutic target for protein kinase Cα-based triple-negative breast cancer cells
    Chia-Jen Lee et al, 2016, Oncotarget CrossRef
11. NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression
    Guanzhao Zong et al, 2023, Experimental Cell Research CrossRef
12. An Update on Protein Kinases as Therapeutic Targets—Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein–Protein Interactions
    Mulate Zerihun et al, 2023, International Journal of Molecular Sciences CrossRef